Note: There are 69,164 people included in this study.s
Did not die | Died | |
---|---|---|
Does not drink coffee | 5438 | 1039 |
Drinks coffee occasionally | 29712 | 4440 |
Drinks coffee regularly | 24934 | 3601 |
Define events A = died and B = non-coffee drinker. Calculate the following for a randomly selected person in the cohort:
Go to the ae-07-[GITHUB USERNAME]
repo, clone it, and start a new project in RStudio. See the Lab 01 for more detailed instructions about cloning a repo and starting a new project.
Run the following code to configure Git. Fill in your GitHub username and the email address associated with your GitHub account.
library(usethis)
use_git_config(user.name = "your github username", user.email ="your email")
library(tidyverse)
The following tables are representative of the SIROCCO trial (Bleecker et al., 2016), which examined the safety and efficacy of benralizumab for patients with severe, poorly controlled asthma. The tables present baseline demographic information for patients enrolled in the file. There were 1204 patients in this study.
You may knit the document to see the tables. “Q4W” means “every four weeks” and “Q8W” means "every eight weeks.
Female | Male | |
---|---|---|
Benralizumab Q4W | 274 | 124 |
Benralizumab Q8W | 253 | 146 |
Placebo | 269 | 138 |
Asian | Black | Other | White | |
---|---|---|---|---|
Benralizumab Q4W | 54 | 15 | 44 | 285 |
Benralizumab Q8W | 50 | 15 | 47 | 287 |
Placebo | 50 | 16 | 39 | 302 |
Answer the following questions using the table provided above (knit this document first to see the tables!). If a probability cannot be calculated, indicate what additional information is needed in order to do so.